NCT06260527 - Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions

Chinese Healthy Volunteer

Interventions

DRUG

ARTS-011

Single ascending dose (SAD): 3mg, 10mg, 20mg, 40mg, and 60mg. Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days. Food effect study: single dose of ARTS-011 under the fasting and high-fat meal.

DRUG

Placebo

Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days. Multiple ascending dose (MAD): 10mg QD, 20mg QD, and 40mg QD X 7 days.

Trial Locations (1)

100050

Beijing Friendship Hospital, Capital Medical University, Beijing